-
1
-
-
0025167093
-
Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II
-
Orchard TJ, Dorman JS, Maser RE, et al. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes. 1990;39(9):1116-1124.
-
(1990)
Diabetes
, vol.39
, Issue.9
, pp. 1116-1124
-
-
Orchard, T.J.1
Dorman, J.S.2
Maser, R.E.3
-
2
-
-
26444611430
-
Systematic review on urine albumin testing for early detection of diabetic complications
-
Newman DJ, Mattock MB, Dawnay AB, et al. Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess. 2005;9:iii-iv. (Pubitemid 41430113)
-
(2005)
Health Technology Assessment
, vol.9
, Issue.30
-
-
Newman, D.J.1
Mattock, M.B.2
Dawnay, A.B.S.3
Kerry, S.4
McGuire, A.5
Yaqoob, M.6
Hitman, G.A.7
Hawke, C.8
-
3
-
-
14044256959
-
-
US Renal Data System. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
-
US Renal Data System. USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2004.
-
(2004)
USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States
-
-
-
4
-
-
0035856920
-
Global and societal implications of the diabetes epidemic
-
DOI 10.1038/414782a
-
Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782-787. (Pubitemid 34000780)
-
(2001)
Nature
, vol.414
, Issue.6865
, pp. 782-787
-
-
Zimmet, P.1
Alberti, K.G.M.M.2
Shaw, J.3
-
5
-
-
0025950787
-
Mechanisms of diabetic hyperfiltration
-
Bank N. Mechanisms of diabetic hyperfiltration. Kidney Int. 1991;40(4):792-807.
-
(1991)
Kidney Int
, vol.40
, Issue.4
, pp. 792-807
-
-
Bank, N.1
-
6
-
-
0026551330
-
Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus
-
Vora JP, Dolben J, Dean JD, et al. Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int. 1992;41(4):829-835.
-
(1992)
Kidney Int
, vol.41
, Issue.4
, pp. 829-835
-
-
Vora, J.P.1
Dolben, J.2
Dean, J.D.3
-
7
-
-
0029827650
-
Development and progression of renal disease in Pima Indians with non- Insulin-dependent diabetes mellitus
-
DOI 10.1056/NEJM199611283352203
-
Nelson DG, Bennett, PH, Beck GJ, et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. N Engl J Med. 1996:335(22):1636-1642. (Pubitemid 26392728)
-
(1996)
New England Journal of Medicine
, vol.335
, Issue.22
, pp. 1636-1642
-
-
Nelson, R.G.1
Bennett, P.H.2
Beck, G.J.3
Tan, M.4
Knowler, W.C.5
Mitch, W.E.6
Hirschman, G.H.7
Myers, B.D.8
-
8
-
-
0036176161
-
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
-
National Kidney Foundation
-
National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am Kidney Dis. 2002;39(suppl 1):S1-S266.
-
(2002)
Am Kidney Dis
, vol.39
, Issue.SUPPL. 1
-
-
-
9
-
-
0030377443
-
Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio
-
Warram JH, Gearing G, Laffel L, Krolewski AS. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol. 1996;7(6):930-937. (Pubitemid 27465988)
-
(1996)
Journal of the American Society of Nephrology
, vol.7
, Issue.6
, pp. 930-937
-
-
Warram, J.H.1
Gearin, G.2
Laffel, L.3
Krolewski, A.S.4
-
10
-
-
33845760213
-
KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease
-
DOI 10.1053/j.ajkd.2006.12.005, PII S0272638606018439
-
KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(2 suppl 2):S12-S154. (Pubitemid 46185743)
-
(2007)
American Journal of Kidney Diseases
, vol.49
, Issue.2 SUPPL. 2
-
-
-
13
-
-
0026734156
-
Renal injury from angiotensin II-mediated hypertension
-
Johnson RJ, Alpers CE, Yoshimura A, et al. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992;19(5):464-474.
-
(1992)
Hypertension
, vol.19
, Issue.5
, pp. 464-474
-
-
Johnson, R.J.1
Alpers, C.E.2
Yoshimura, A.3
-
14
-
-
35348917135
-
Management of Glycemia in Patients with Diabetes Mellitus and CKD
-
DOI 10.1053/j.ajkd.2007.08.012, PII S0272638607011493
-
Lubowsky ND, Siegel R, Pittas AG. Management of glycemia in patients with diabetes mellitus and CKD. Am J Kidney Dis. 2007;50(5):865-879. (Pubitemid 47588565)
-
(2007)
American Journal of Kidney Diseases
, vol.50
, Issue.5
, pp. 865-879
-
-
Lubowsky, N.D.1
Siegel, R.2
Pittas, A.G.3
-
15
-
-
0030944242
-
A low-protein diet improves insulin sensitivity of endogenous glucose production in predialytic uremic patients
-
Rigalleau V, Blanchetier V, Combe C, et al. A low-protein diet improves insulin sensitivity of endogenous glucose production in predialytic uremic patients. Am J Clin Nutr. 1997;65(5):1512-1516. (Pubitemid 27187766)
-
(1997)
American Journal of Clinical Nutrition
, vol.65
, Issue.5
, pp. 1512-1516
-
-
Rigalleau, V.1
Blanchetier, V.2
Combe, C.3
Guillot, C.4
Deleris, G.5
Aubertin, J.6
Aparicio, M.7
Gin, H.8
-
16
-
-
20544476937
-
Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease
-
DOI 10.1681/ASN.2004060447
-
Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol. 2005;16(2):459-466. (Pubitemid 41725142)
-
(2005)
Journal of the American Society of Nephrology
, vol.16
, Issue.2
, pp. 459-466
-
-
Poggio, E.D.1
Wang, X.2
Greene, T.3
Van Lente, F.4
Hall, P.M.5
-
17
-
-
24344499832
-
An alternative formula to the cockcroft-gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes
-
DOI 10.1681/ASN.2004080692
-
Ibrahim H, Mondress M, Tello A, Fan Y, Koopmeiners J, Thomas W. An alternative formula to the Cockcroft-Gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes. J Am Soc Nephrol. 2005;16(4):1051-1060. (Pubitemid 41710315)
-
(2005)
Journal of the American Society of Nephrology
, vol.16
, Issue.4
, pp. 1051-1060
-
-
Ibrahim, H.1
Mondress, M.2
Tello, A.3
Fan, Y.4
Koopmeiners, J.5
Thomas, W.6
-
18
-
-
0345505677
-
Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: An indicator of more advanced glomerular lesions
-
DOI 10.2337/diabetes.52.4.1036
-
Caramori ML, Fioretto P, Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes. 2003;52(4):1036-1040. (Pubitemid 36384275)
-
(2003)
Diabetes
, vol.52
, Issue.4
, pp. 1036-1040
-
-
Caramori, M.L.1
Fioretto, P.2
Mauer, M.3
-
19
-
-
0026683655
-
Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion
-
Lane PH, Steffes MW, Mauer SM. Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes. 1992;41(5):581-586.
-
(1992)
Diabetes
, vol.41
, Issue.5
, pp. 581-586
-
-
Lane, P.H.1
Steffes, M.W.2
Mauer, S.M.3
-
20
-
-
38349019064
-
Asymmetrical dimethylarginine in renal disease: Limits of variation or variation limits
-
Jacob J, Tsao PS. Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits. Am J Nephrol. 2007;28(2):224-237.
-
(2007)
Am J Nephrol
, vol.28
, Issue.2
, pp. 224-237
-
-
Jacob, J.1
Tsao, P.S.2
-
21
-
-
33947266626
-
Relationship between arterial hypertension and renal damage in chronic kidney disease: Insights from ABPM
-
Paoletti E, Bellino D, Amidone M, Rolla D, Cannella G. Relationship between arterial hypertension and renal damage in chronic kidney disease: insights from ABPM. J Nephrol. 2006;19(6):778-782. (Pubitemid 46415984)
-
(2006)
Journal of Nephrology
, vol.19
, Issue.6
, pp. 778-782
-
-
Paoletti, E.1
Bellino, D.2
Amidone, M.3
Rolla, D.4
Cannella, G.5
-
22
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
DOI 10.1016/S0140-6736(98)07019-6
-
UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-853. (Pubitemid 28416718)
-
(1998)
Lancet
, vol.352
, Issue.9131
, pp. 837-853
-
-
Turner, R.1
-
23
-
-
7744237066
-
Metabolic effects of carvedilol vs metoprotol in patients with type 2 diabetes mellinis and hypertension
-
Bakris GL, Fonesca V, Katholi RE, et al. Metabolic effects of carvedilol vs metoprotol in patients with type 2 diabetes mellinis and hypertension. JAMA. 2004;292(18):2227-2236.
-
(2004)
JAMA
, vol.292
, Issue.18
, pp. 2227-2236
-
-
Bakris, G.L.1
Fonesca, V.2
Katholi, R.E.3
-
24
-
-
63849163945
-
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
-
Fellström BC, Jardine AG, Schmieder RE, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360(14):1395-1407.
-
(2009)
N Engl J Med
, vol.360
, Issue.14
, pp. 1395-1407
-
-
Fellström, B.C.1
Jardine, A.G.2
Schmieder, R.E.3
-
25
-
-
22344458137
-
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
-
DOI 10.1056/NEJMoa043545
-
Wanner C, Krane V, März W, et al. Atorvastatin in patients with type 2 diabetes mellittis undergoing hemodialysis. N Engl J Med. 2005;353:238-248. (Pubitemid 41058323)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.3
, pp. 238-248
-
-
Wanner, C.1
Krane, V.2
Marz, W.3
Olschewski, M.4
Mann, J.F.E.5
Ruf, G.6
Ritz, E.7
-
28
-
-
0025910414
-
Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement insulin-dependent diabetes mellitus
-
Tuttle KR, Bruton JL, Perusek MC, Lancaster JL, Kopp DT, DeFronzo RA. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement insulin-dependent diabetes mellitus. N Engl J Med. 1991;324(23):1626-1632.
-
(1991)
N Engl J Med
, vol.324
, Issue.23
, pp. 1626-1632
-
-
Tuttle, K.R.1
Bruton, J.L.2
Perusek, M.C.3
Lancaster, J.L.4
Kopp, D.T.5
Defronzo, R.A.6
-
29
-
-
0027319737
-
Effects of insulin-like growth factor I on renal function in normal men
-
Hirschberg R, Brunori G, Kopple JD, Guler HP. Effects of insulin-like growth factor I on renal function in normal men. Kidney Int. 1993;43(2):387-397. (Pubitemid 23162832)
-
(1993)
Kidney International
, vol.43
, Issue.2
, pp. 387-397
-
-
Hirschberg, R.1
Brunori, G.2
Kopple, J.D.3
Guler, H.-P.4
-
30
-
-
0026827633
-
The growth hormone-insulin-like growth factor I axis and renal glomerular filtration
-
Hirschberg R, Kopple JD. The growth hormone-insulin-like growth factor I axis and renal glomerular filtration. J Am Soc Nephrol. 1992;2(9):1417-1422.
-
(1992)
J Am Soc Nephrol
, vol.2
, Issue.9
, pp. 1417-1422
-
-
Hirschberg, R.1
Kopple, J.D.2
-
31
-
-
0030005523
-
Protein glycation in the kidney: Role in diabetes and aging
-
Vlassara H. Protein glycation in the kidney: role in diabetes and aging. Kidney Int. 1996;49(6):1795-1804. (Pubitemid 26188071)
-
(1996)
Kidney International
, vol.49
, Issue.6
, pp. 1795-1804
-
-
Vlassara, H.1
-
32
-
-
0027174150
-
Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy
-
Passariello N, Sepe J, Marrazzo G, et al. Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy. Diabetes Care. 1993;16(5):789-795. (Pubitemid 23127187)
-
(1993)
Diabetes Care
, vol.16
, Issue.5
, pp. 789-795
-
-
Passariello, N.1
Sepe, J.2
Marrazzo, G.3
De Cicco, A.4
Peluso, A.5
Pisano, M.C.A.6
Sgambato, S.7
Tesauro, P.8
D'Onofrio, F.9
-
33
-
-
0034118392
-
Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists
-
DOI 10.1046/j.1523-1755.2000.00031.x
-
Taal MW, Brenner BM. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int. 2000;57(5):1803-1817. (Pubitemid 30252273)
-
(2000)
Kidney International
, vol.57
, Issue.5
, pp. 1803-1817
-
-
Taal, M.W.1
Brenner, B.M.2
-
34
-
-
0347133334
-
Poor Control of Risk Factors for Vascular Disease among Adults with Previously Diagnosed Diabetes
-
DOI 10.1001/jama.291.3.335
-
Saydah SB, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291(3):335-342. (Pubitemid 38101606)
-
(2004)
Journal of the American Medical Association
, vol.291
, Issue.3
, pp. 335-342
-
-
Saydah, S.H.1
Fradkin, J.2
Cowie, C.C.3
-
35
-
-
0034627208
-
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study
-
Mogensen CE, Neldam S, Tikkanen I, et al. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ. 2000;321(7274):1440-1444.
-
(2000)
BMJ
, vol.321
, Issue.7274
, pp. 1440-1444
-
-
Mogensen, C.E.1
Neldam, S.2
Tikkanen, I.3
-
36
-
-
20444494954
-
Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: The role of aldosterone
-
DOI 10.1055/s-2005-861359
-
Schjoedt KJ, Jacobsen P, Rossing K, Boomsma F, Parving HH. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nepbropathy: the role of aldosterone. Horm Metab Res. 2005;37(suppl 1):4-8. (Pubitemid 40813887)
-
(2005)
Hormone and Metabolic Research
, vol.37
, Issue.SUPPL. 1
-
-
Schjoedt, K.J.1
Jacobsen, P.2
Rossing, K.3
Boomsma, F.4
Parving, H.H.5
-
37
-
-
32844467281
-
Beneficial impact of spironolactone in diabetic nephropathy
-
DOI 10.1111/j.1523-1755.2005.00756.x, PII 4495629
-
Schjoedt KJ, Rossing K, Juhl TR, et al. Beneficial impact of spironolactone in diabetic nephropathy. Kidney Int. 2005;68:2829-2836. (Pubitemid 43251030)
-
(2005)
Kidney International
, vol.68
, Issue.6
, pp. 2829-2836
-
-
Schjoedt, K.J.1
Rossing, K.2
Juhl, T.R.3
Boomsma, F.4
Rossing, P.5
Tarnow, L.6
Parving, H.-H.7
-
38
-
-
44849114597
-
Aliskiren combined with losartan in type 2 diabetes and nephropathy
-
DOI 10.1056/NEJMoa0708379
-
Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med. 2008;358(23):2433-2446. (Pubitemid 351793017)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.23
, pp. 2433-2446
-
-
Parving, H.-H.1
Persson, F.2
Lewis, J.B.3
Lewis, E.J.4
Hollenberg, N.K.5
-
39
-
-
42049107348
-
Telmisartan, ramipril, or both in patients at high risk for vascular events
-
Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547-1559.
-
(2008)
N Engl J Med
, vol.358
, Issue.15
, pp. 1547-1559
-
-
Yusuf, S.1
Teo, K.K.2
Pogue, J.3
-
40
-
-
33845367689
-
Drug interactions of medications commonly used in diabetes
-
DOI 10.2337/diaspect.19.4.202
-
Triplitt C. Drug interactions of medications commonly used in diabetes. Diabetes Spectrum. 2006;19:202-211. (Pubitemid 44885518)
-
(2006)
Diabetes Spectrum
, vol.19
, Issue.4
, pp. 202-211
-
-
Triplitt, C.1
-
41
-
-
0027286787
-
Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes
-
DOI 10.1016/0140-6736(93)90816-Y
-
Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet. 1993;341(8856)1:1306-1309. (Pubitemid 23148093)
-
(1993)
Lancet
, vol.341
, Issue.8856
, pp. 1306-1309
-
-
Wang, P.H.1
Lau, J.2
Chalmers, T.C.3
-
42
-
-
0027370108
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellilus
-
The Diabetes Control and Complications Trial Rcscarch Group
-
The Diabetes Control and Complications Trial Rcscarch Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellilus. N Engl J Med. 1993;329(14):977-986.
-
(1993)
N Engl J Med
, vol.329
, Issue.14
, pp. 977-986
-
-
-
43
-
-
0029147687
-
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
-
Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103-117.
-
(1995)
Diabetes Res Clin Pract
, vol.28
, Issue.2
, pp. 103-117
-
-
Ohkubo, Y.1
Kishikawa, H.2
Araki, E.3
-
44
-
-
0030812652
-
Predialysis glycemic control is an independent predictor of clinical outcome in type II diabetics on continuous ambulatory peritoneal dialysis
-
Yu CC, Wu MS, Wu CH, et al. Predialysis glycemic control is an independent predictor of clinical outcome in type II diabetics on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1997;17(3):262-268. (Pubitemid 27470494)
-
(1997)
Peritoneal Dialysis International
, vol.17
, Issue.3
, pp. 262-268
-
-
Yu, C.-C.1
Wu, M.-S.2
Wu, C.-H.3
Yang, C.-W.4
Huang, J.-Y.5
Hong, J.-J.6
Chiang, C.-Y.F.7
Leu, M.-L.8
Huang, C.-C.9
-
45
-
-
0035347825
-
Glycemic Control Is a Predictor of Survival for Diabetic Patients on Hemodialysis
-
Morioka T, Emoto M, Tabata T, et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care. 2001;24(5):909-913. (Pubitemid 33636068)
-
(2001)
Diabetes Care
, vol.24
, Issue.5
, pp. 909-913
-
-
Morioka, T.1
Emoto, M.2
Tabata, T.3
Shoji, T.4
Tahara, H.5
Kishimoto, H.6
Ishimura, E.7
Nishizawa, Y.8
-
46
-
-
0034071036
-
Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients
-
Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23(suppl 2):B21-B29. (Pubitemid 30185774)
-
(2000)
Diabetes Care
, vol.23
, Issue.SUPPL. 2
-
-
Shichiri, M.1
Kishikawa, H.2
Ohkubo, Y.3
Wake, N.4
-
47
-
-
0027275397
-
The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus
-
DOI 10.1056/NEJM199307293290502
-
Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993;329(5):304-309. (Pubitemid 23210681)
-
(1993)
New England Journal of Medicine
, vol.329
, Issue.5
, pp. 304-309
-
-
Reichard, P.1
Nilsson, B.-Y.2
Rosenqvist, U.3
-
48
-
-
33746588255
-
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. a consensus statement from the American diabetes association and the European association for the study of diabetes
-
DOI 10.2337/dc06-9912
-
Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006;29(8):1963-1972. (Pubitemid 44156663)
-
(2006)
Diabetes Care
, vol.29
, Issue.8
, pp. 1963-1972
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
Heine, R.J.4
Holman, R.R.5
Sherwin, R.6
Zinman, B.7
-
49
-
-
0031053808
-
An overview of metformin in the treatment of type 2 diabetes mellitus
-
DOI 10.1016/S0002-9343(96)00353-1, PII S0002934396003531
-
Davidson MB, Peters AL. An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med. 1997;102(1):99-110. (Pubitemid 27089992)
-
(1997)
American Journal of Medicine
, vol.102
, Issue.1
, pp. 99-110
-
-
Davidson, M.B.1
Peters, A.L.2
-
50
-
-
20844435106
-
Oral antihyperglycemic agents and renal disease: New agents, new concepts
-
DOI 10.1681/ASN.2004110974
-
Yale JF. Oral antihyperglycemic agents and renal disease: new agents, new concepts. J Am Soc Nephrol. 2005;16(suppl 1):S7-S10. (Pubitemid 41725074)
-
(2005)
Journal of the American Society of Nephrology
, vol.16
, Issue.3 SUPPL. 1
-
-
Yale, J.-F.1
-
51
-
-
0042532061
-
Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure
-
Inoue T, Shibahara N, Miyagawa K, et al. Pharmacokinetics of nateglinide and its metabolites in subjects sith type 2 diabetes mellitus and renal failure. Clin Nephrol. 2003;60(2):90-95. (Pubitemid 36975183)
-
(2003)
Clinical Nephrology
, vol.60
, Issue.2
, pp. 90-95
-
-
Inoue, T.1
Shibahara, N.2
Miyagawa, K.3
Itahana, R.4
Izumi, M.5
Nakanishi, T.6
Takamitsu, Y.7
-
52
-
-
0037365688
-
Hypoglycemia due to nateglinide administration in diabetic patient with chronic renal failure
-
DOI 10.1016/S0168-8227(02)00242-5, PII S0168822702002425
-
Nagai T, Imamura M, Iizuka K, Mori M. Hypoglycemia due to nateglinide administration in diabetic patient with chronic renal failure. Diabetes Res Clin Pract. 2003;59(3):19l-194. (Pubitemid 36183302)
-
(2003)
Diabetes Research and Clinical Practice
, vol.59
, Issue.3
, pp. 191-194
-
-
Nagai, T.1
Imamura, M.2
Iizuka, K.3
Mori, M.4
-
53
-
-
0035030427
-
Single- And multiple-dose pharmacokinetics of repaglinide in patients with type 2 diabetes and renal impairment
-
DOI 10.1007/s002280100280
-
Schumacher S, Abbasi I, Weise D, et al. Single- and multiple-dose pharmacokinetics of repaglinide in patients with type 2 diabetes and renal impairment. Eur J Clin Pharmacol. 2001;57(2):147-152. (Pubitemid 32449136)
-
(2001)
European Journal of Clinical Pharmacology
, vol.57
, Issue.2
, pp. 147-152
-
-
Schumacher, S.1
Abbasi, I.2
Weise, D.3
Hatorp, V.4
Sattler, K.5
Sieber, J.6
Hasslacher, C.7
-
54
-
-
7044271016
-
Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease
-
DOI 10.1111/j.0894-0959.2004.17346.x
-
Snyder RW, Berns JS. Use of insulin and oral hypoglcemic medications in patients with diabetes mellitus and advanced kidney disease. Semin Dial. 2004;17(5):365-370. (Pubitemid 39422090)
-
(2004)
Seminars in Dialysis
, vol.17
, Issue.5
, pp. 365-370
-
-
Snyder, R.W.1
Berns, J.S.2
-
55
-
-
0037258604
-
Rosiglitazone reduces urinary albumin excretion in type II diabetes
-
DOI 10.1038/sj.jhh.1001444
-
Bakris G, Viberti G, Weston WM, Heise M, Porter LE, Freed MI. Rosiglitazone reduces urinary albumin excretion in type II diabetes. J Hum Hypertens. 2003;17:7-12. (Pubitemid 36163426)
-
(2003)
Journal of Human Hypertension
, vol.17
, Issue.1
, pp. 7-12
-
-
Bakris, G.1
Viberti, G.2
Weston, W.M.3
Heise, M.4
Porter, L.E.5
Freed, M.I.6
-
56
-
-
0034758754
-
Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria
-
DOI 10.1053/meta.2001.26703
-
Nakamura T, Ushiyama C, Osada S, Hara M, Shimada N, Koide H. Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria. Metabolism. 2001;50(10):1193-1196. (Pubitemid 33034703)
-
(2001)
Metabolism: Clinical and Experimental
, vol.50
, Issue.10
, pp. 1193-1196
-
-
Nakamura, T.1
Ushiyama, C.2
Osada, S.3
Hara, M.4
Shimada, N.5
Koide, H.6
-
57
-
-
23844472901
-
Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption
-
DOI 10.1038/nm1278
-
Guan Y, Hao C, Cha DR, et al. Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Nat Med. 2005;11(8):86l-866. (Pubitemid 41161118)
-
(2005)
Nature Medicine
, vol.11
, Issue.8
, pp. 861-866
-
-
Guan, Y.1
Hao, C.2
Cha, D.R.3
Rao, R.4
Lu, W.5
Kohan, D.E.6
Magnuson, M.A.7
Redha, R.8
Zhang, Y.9
Breyer, M.D.10
-
58
-
-
0344304678
-
Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: A Consensus Statement from the American Heart Association and American Diabetes Association
-
DOI 10.1161/01.CIR.0000103683.99399.7E
-
Nesto RW, Bell D, Bonow RO, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Circulation. 2003;108(23):2941-2948. (Pubitemid 37517824)
-
(2003)
Circulation
, vol.108
, Issue.23
, pp. 2941-2948
-
-
Nesto, R.W.1
Bell, D.2
Bonow, R.O.3
Fonseca, V.4
Grundy, S.M.5
Horton, E.S.6
Le Winter, M.7
Porte, D.8
Semenkovich, C.F.9
Smith, S.10
Young, L.H.11
Kahn, R.12
-
59
-
-
34250212715
-
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
-
Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007;356(24):2457-2471. (Pubitemid 46919772)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.24
, pp. 2457-2471
-
-
Nissen, S.E.1
Wolski, K.2
-
60
-
-
67649177574
-
-
US Food and Drug Administration Accessed April 30, 2009
-
US Food and Drug Administration. http://www.accessdata.fda.gov/scripts/ cder/drugsatfda/index.cfm?fuseaction=Search.Label-ApprovalHistory. Accessed April 30, 2009.
-
-
-
-
61
-
-
34548590934
-
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus
-
Lincoff MA, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus. JAMA. 2007;298(10):1180-1188.
-
(2007)
JAMA
, vol.298
, Issue.10
, pp. 1180-1188
-
-
Lincoff, M.A.1
Wolski, K.2
Nicholls, S.J.3
Nissen, S.E.4
-
62
-
-
11844250564
-
Insulin analogues
-
DOI 10.1056/NEJMra040832
-
Hirsch IB. Insulin analogues. N Engl J Med. 2005;352(2):174-183. (Pubitemid 40096614)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.2
, pp. 174-183
-
-
Hirsch, I.B.1
-
63
-
-
31544464630
-
Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus [8]
-
DOI 10.1093/ndt/gfi205
-
Ersoy A, Ersoy C, Altinay T. Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus. Nephrol Dial Transplant. 2006;21(2):553-554. (Pubitemid 43160027)
-
(2006)
Nephrology Dialysis Transplantation
, vol.21
, Issue.2
, pp. 553-554
-
-
Ersoy, A.1
Ersoy, C.2
Altinay, T.3
-
64
-
-
0033661254
-
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro
-
Lepore M, Pampanelli S, Fanelli C, et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes. 2000:49(12);2l42-2148.
-
(2000)
Diabetes
, vol.49
, Issue.12
-
-
Lepore, M.1
Pampanelli, S.2
Fanelli, C.3
-
65
-
-
33645967817
-
Insulin detemir under steady state conditions: No accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes
-
Butt S, Tusek C, Jacobsen LV, et al. Insulin detemir under steady state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes. Diabetic Medicine. 2006;23:522-528.
-
(2006)
Diabetic Medicine
, vol.23
, pp. 522-528
-
-
Butt, S.1
Tusek, C.2
Jacobsen, L.V.3
-
66
-
-
0035656524
-
Insulin therapy during peritoneal dialysis: Pros and cons of various forms of administration
-
Quellhorst E. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration. J Am Soc Nephrol. 2002;13(suppl 1):S92-96.
-
(2002)
J Am Soc Nephrol
, vol.13
, Issue.SUPPL. 1
-
-
Quellhorst, E.1
-
67
-
-
0035347825
-
Glycemic Control Is a Predictor of Survival for Diabetic Patients on Hemodialysis
-
Morioka T, Emoto M, Tabata T, et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care. 2001;24(5):909-913. (Pubitemid 33636068)
-
(2001)
Diabetes Care
, vol.24
, Issue.5
, pp. 909-913
-
-
Morioka, T.1
Emoto, M.2
Tabata, T.3
Shoji, T.4
Tahara, H.5
Kishimoto, H.6
Ishimura, E.7
Nishizawa, Y.8
-
68
-
-
33645231696
-
The effect of glucose added to the dialysis fluid on blood pressure, blood glucose and quality of life in hemodialysis patients: A placebo-controlled crossover study
-
Sangill M, Pedersen EB. The effect of glucose added to the dialysis fluid on blood pressure, blood glucose and quality of life in hemodialysis patients: a placebo-controlled crossover study. Am J Kidney Dis. 2006,47(4):636-643.
-
(2006)
Am J Kidney Dis
, vol.47
, Issue.4
, pp. 636-643
-
-
Sangill, M.1
Pedersen, E.B.2
-
69
-
-
0037373850
-
Assessing glycemic control in patients with diabetes and end-stage renal failure
-
DOI 10.1053/ajkd.2003.50114
-
Ansari A, Thomas S, Goldsmith D. Assessing glycemic control in patients with diabetes and end-stage renal failure. Am J Kidney Dis. 2003;41(3):523-531. (Pubitemid 36278368)
-
(2003)
American Journal of Kidney Diseases
, vol.41
, Issue.3
, pp. 523-531
-
-
Ansari, A.1
Thomas, S.2
Goldsmith, D.3
-
70
-
-
10744233539
-
Diabetes mellitus after transplant: Relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy
-
DOI 10.1097/01.TP.0000084295.67371.11
-
Sato T, Inagaki A, Uchida K, et al. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosoprine A-based therapy. Transplantation. 2003;76(9):1320-1326. (Pubitemid 37430718)
-
(2003)
Transplantation
, vol.76
, Issue.9
, pp. 1320-1326
-
-
Sato, T.1
Inagaki, A.2
Uchida, K.3
Ueki, T.4
Goto, N.5
Matsuoka, S.6
Katayama, A.7
Haba, T.8
Tominaga, Y.9
Okajima, Y.10
Ohta, K.11
Suga, H.12
Taguchi, S.13
Kakiya, S.14
Itatsu, T.15
Kobayashi, T.16
Nakao, A.17
-
71
-
-
0033031089
-
Risk for posttransplant diabetes mellitus with current immunosuppressive medications
-
Weir MR, Fink JC. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis. 1999;34(1):1-13. (Pubitemid 29318789)
-
(1999)
American Journal of Kidney Diseases
, vol.34
, Issue.1
, pp. 1-13
-
-
Weir, M.R.1
Fink, J.C.2
-
72
-
-
33846680173
-
Early steroid withdrawal therapy in renal transplant recipients: A steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol
-
DOI 10.1111/j.1399-0012.2006.00613.x
-
Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ. Early steroid withdrawal therapy in renal transplantation recipients: a steroid free sirolimus and CellCept based calcineurin inhibitor-minimization protocol. Clin Transplant. 2007;21(1):101-109. (Pubitemid 46189594)
-
(2007)
Clinical Transplantation
, vol.21
, Issue.1
, pp. 101-109
-
-
Jaber, J.J.1
Feustel, P.J.2
Elbahloul, O.3
Conti, A.D.4
Gallichio, M.H.5
Conti, D.J.6
-
73
-
-
0030951564
-
Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: A prospective trial in renal transplants
-
DOI 10.1007/s001470050041
-
Kim YS, Kim MS, Kim SI, Lim SK, Lee HY, Han DS, Park K. Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: a prospective trial in renal transplants. Transpl Int. 1997;10(3):197-201. (Pubitemid 27174073)
-
(1997)
Transplant International
, vol.10
, Issue.3
, pp. 197-201
-
-
Kim, Y.S.1
Kim, M.S.2
Kim, S.I.3
Lim, S.K.4
Lee, H.Y.5
Han, D.S.6
Park, K.7
-
75
-
-
0020526172
-
Reversible diminished insulin requirement during acute renal failure
-
Naschitz JE, Barak C, Yeshurun D. Reversible diminished insulin requirement during acute renal failure. Postgrad Med J. 1983;59(690):269-27l.
-
(1983)
Postgrad Med J
, vol.59
, Issue.690
-
-
Naschitz, J.E.1
Barak, C.2
Yeshurun, D.3
-
76
-
-
0035199665
-
Lower-extremity peripheral arterial disease among patients with end-stage renal disease
-
O'Hare A, Johansen K. Lower extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol. 2001;12(12):2838-2847. (Pubitemid 33115433)
-
(2001)
Journal of the American Society of Nephrology
, vol.12
, Issue.12
, pp. 2838-2847
-
-
O'Hare, A.1
Johansen, K.2
-
77
-
-
0037472879
-
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
-
DOI 10.1056/NEJMoa021778
-
Gaede P, Vedel P, Larsen N, Jensen GV, Parin HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383-393. (Pubitemid 36159355)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.5
, pp. 383-393
-
-
Gaede, P.1
Vedel, P.2
Larsen, N.3
Jensen, G.V.H.4
Parving, H.-H.5
Pedersen, O.6
|